337 related articles for article (PubMed ID: 33576035)
1. Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP-Activated Protein Kinase Signaling Pathway.
Lan T; Yu Y; Zhang J; Li H; Weng Q; Jiang S; Tian S; Xu T; Hu S; Yang G; Zhang Y; Wang W; Wang L; Zhu Q; Rong X; Guo J
Hepatology; 2021 Aug; 74(2):686-703. PubMed ID: 33576035
[TBL] [Abstract][Full Text] [Related]
2. Neferine ameliorates nonalcoholic steatohepatitis through regulating AMPK pathway.
Wang MY; Zhang SS; An MF; Xia YF; Fan MS; Sun ZR; Zhang LJ; Zhao YL; Sheng J; Wang XJ
Phytomedicine; 2023 Jun; 114():154798. PubMed ID: 37031639
[TBL] [Abstract][Full Text] [Related]
3. A non-mitogenic FGF4 analog alleviates non-alcoholic steatohepatitis through an AMPK-dependent pathway.
Wang L; Dong W; Gao H; Chen C; Liang S; Ye X; Liu Y; Hou Y; Fan L; Pan T; Wang Z; Chen Y; Luo Y; Song L
Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166560. PubMed ID: 36167161
[TBL] [Abstract][Full Text] [Related]
4. FTZ attenuates liver steatosis and fibrosis in the minipigs with type 2 diabetes by regulating the AMPK signaling pathway.
Wang H; Huang M; Bei W; Yang Y; Song L; Zhang D; Zhan W; Zhang Y; Chen X; Wang W; Wang L; Guo J
Biomed Pharmacother; 2021 Jun; 138():111532. PubMed ID: 34311531
[TBL] [Abstract][Full Text] [Related]
5. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
[TBL] [Abstract][Full Text] [Related]
6. Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling.
Lan T; Jiang S; Zhang J; Weng Q; Yu Y; Li H; Tian S; Ding X; Hu S; Yang Y; Wang W; Wang L; Luo D; Xiao X; Piao S; Zhu Q; Rong X; Guo J
Hepatology; 2022 Jul; 76(1):155-171. PubMed ID: 34717002
[TBL] [Abstract][Full Text] [Related]
7. Gastrodin Improves Nonalcoholic Fatty Liver Disease Through Activation of the Adenosine Monophosphate-Activated Protein Kinase Signaling Pathway.
Wan J; Zhang Y; Yang D; Liang Y; Yang L; Hu S; Liu Z; Fang Q; Tian S; Ding Y
Hepatology; 2021 Dec; 74(6):3074-3090. PubMed ID: 34297426
[TBL] [Abstract][Full Text] [Related]
8. Salidroside Activates the AMP-Activated Protein Kinase Pathway to Suppress Nonalcoholic Steatohepatitis in Mice.
Hu M; Zhang D; Xu H; Zhang Y; Shi H; Huang X; Wang X; Wu Y; Qi Z
Hepatology; 2021 Dec; 74(6):3056-3073. PubMed ID: 34292604
[TBL] [Abstract][Full Text] [Related]
9. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
10. From overnutrition to liver injury: AMP-activated protein kinase in nonalcoholic fatty liver diseases.
Zhao P; Saltiel AR
J Biol Chem; 2020 Aug; 295(34):12279-12289. PubMed ID: 32651233
[TBL] [Abstract][Full Text] [Related]
11. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
[TBL] [Abstract][Full Text] [Related]
12. Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis.
Gluais-Dagorn P; Foretz M; Steinberg GR; Batchuluun B; Zawistowska-Deniziak A; Lambooij JM; Guigas B; Carling D; Monternier PA; Moller DE; Bolze S; Hallakou-Bozec S
Hepatol Commun; 2022 Jan; 6(1):101-119. PubMed ID: 34494384
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling.
Li SW; Takahara T; Que W; Fujino M; Guo WZ; Hirano SI; Ye LP; Li XK
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G450-G463. PubMed ID: 33439102
[TBL] [Abstract][Full Text] [Related]
14. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
[TBL] [Abstract][Full Text] [Related]
15. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
16. The role of AMPKα2 in the HFD-induced nonalcoholic steatohepatitis.
Zhang X; Liu S; Zhang C; Zhang S; Yue Y; Zhang Y; Chen L; Yao Z; Niu W
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165854. PubMed ID: 32502647
[TBL] [Abstract][Full Text] [Related]
17. β-patchoulene protects against non-alcoholic steatohepatitis via interrupting the vicious circle among oxidative stress, histanoxia and lipid accumulation in rats.
Luo H; Xu N; Wu J; Gan Y; Chen L; Guan F; Li M; Li Y; Chen J; Su Z; Liu Y
Int Immunopharmacol; 2021 Sep; 98():107915. PubMed ID: 34198236
[TBL] [Abstract][Full Text] [Related]
18. Integrin β
Guo Q; Furuta K; Lucien F; Gutierrez Sanchez LH; Hirsova P; Krishnan A; Kabashima A; Pavelko KD; Madden B; Alhuwaish H; Gao Y; Revzin A; Ibrahim SH
J Hepatol; 2019 Dec; 71(6):1193-1205. PubMed ID: 31433301
[TBL] [Abstract][Full Text] [Related]
19. Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.
Li S; Li X; Chen F; Liu M; Ning L; Yan Y; Zhang S; Huang S; Tu C
J Nutr Biochem; 2022 Feb; 100():108888. PubMed ID: 34695558
[TBL] [Abstract][Full Text] [Related]
20. Gossypetin Prevents the Progression of Nonalcoholic Steatohepatitis by Regulating Oxidative Stress and AMP-Activated Protein Kinase.
Oh E; Lee J; Cho S; Kim SW; Won K; Shin WS; Gwak SH; Ha J; Jeon SY; Park JH; Song IS; Thoudam T; Lee IK; Kim S; Choi SY; Kim KT
Mol Pharmacol; 2023 Nov; 104(5):214-229. PubMed ID: 37595967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
